Sublingual Semaglutide and Tirzepatide are now available! Get Started
Dashboard
Formulas

Estradiol 0.5 mg/Estriol 2 mg Slow Release (MEM4) Oral Capsules

The Estradiol 0.5 mg/Estriol 2 mg Slow Release (MEM4) Oral Capsules are a hormone replacement therapy (HRT) formulation designed to alleviate symptoms associated with menopause, such as hot flashes, vaginal dryness, and osteoporosis prevention. Each capsule contains a combination of estradiol and estriol, two forms of estrogen, encapsulated with Methocel E4M, a controlled-release polymer. This advanced delivery system ensures a slow and steady release of the hormones into the bloodstream, mimicking the body's natural rhythm and maintaining consistent hormone levels over time. The use of Methocel E4M in the formulation promotes sustained therapeutic effects, reduces the need for frequent dosing, and enhances patient adherence to the treatment regimen. This formulation is specifically tailored for postmenopausal women seeking a more convenient and effective approach to managing the symptoms of menopause and protecting against the associated decrease in bone density.

Want a different strength?
Click the Text Us button below.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Must be E-Prescribed
Get Started
Generate LeafletShow Leaflet
This medication requires a prescription from your doctor
Are you a prescriber? Sign Up
Trusted by 60,357 patients to date.
A group of faces of our past satisfied patients.
A svg symbol of a mortar and pestle with ingredients going in.
Custom made in our compounding labs.
Sliders that show the customization of ingredients.
Personalized treatment for better results.
User with a gear showing the personalization of the formulation.
All strengths and ingredients are tailored to your needs.
This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.
Slow Release Capsules
655e52da70c4007b783c1ae6
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Dosing Calculator

Get general dosing information for a patient by using this calculator.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Formula Information

A small arrow pointing down

Our Estradiol 0.5 mg/Estriol 2 mg Slow Release (MEM4) Oral Capsules are expertly compounded to provide a balanced combination of two forms of estrogen: estradiol, the primary human estrogen, and estriol, a weaker estrogen that is abundant during pregnancy. This formulation is designed to address the needs of patients requiring hormone replacement therapy (HRT), particularly for the management of menopausal symptoms such as hot flashes, night sweats, vaginal dryness, and osteoporosis prevention. The inclusion of Methocel E4M, a hydrophilic matrix forming polymer, allows for a controlled-release mechanism that ensures a steady absorption of the hormones over time, mimicking the body's natural release patterns more closely than immediate-release formulations.

The slow-release feature of these capsules is particularly beneficial for maintaining consistent hormone levels throughout the day, which can help in reducing the incidence of peaks and troughs associated with conventional hormone replacement therapies. This can lead to an improvement in symptom control and a potential reduction in side effects. The Methocel E4M polymer swells and forms a gel-like matrix when it comes into contact with gastric fluids, which then slowly erodes, allowing for the gradual release of estradiol and estriol.

For prescribers, it is important to note that the dosing of our Estradiol 0.5 mg/Estriol 2 mg Slow Release (MEM4) Oral Capsules can be customized to meet the individual needs of patients, based on their hormonal requirements, existing conditions, and response to therapy. The use of this formulation should be guided by clinical goals, patient symptoms, and laboratory monitoring. It is also essential to consider the risks associated with hormone replacement therapy, including cardiovascular disease and breast cancer, and to discuss these with patients prior to initiating treatment.

Patients should be advised that while these capsules are designed to improve convenience with less frequent dosing, adherence to the prescribed regimen is crucial for optimal results. They should also be informed about the potential side effects of hormone replacement therapy, which may include breast tenderness, nausea, bloating, and mood swings. Regular follow-up appointments are necessary to monitor the effectiveness of the therapy and to make any necessary adjustments to the treatment plan.

At Bayview Pharmacy, we are committed to providing high-quality, patient-specific compounding services. Our team of knowledgeable compounding pharmacists is available to answer any questions and provide support to both patients and prescribers. If you have any questions or require further information about our Estradiol 0.5 mg/Estriol 2 mg Slow Release (MEM4) Oral Capsules, or any other compounded medications, please do not hesitate to reach out to us.

Drug Interactions

A small arrow pointing down

The Estradiol 0.5 mg/Estriol 2 mg Slow Release (MEM4) Oral Capsules are a hormone replacement therapy (HRT) designed to alleviate symptoms associated with menopause, such as hot flashes, vaginal dryness, and osteoporosis prevention. The combination of estradiol and estriol aims to mimic the natural estrogen hormones that are reduced during menopause. The Methocel E4M polymer ensures a controlled and sustained release of the hormones, which can lead to more stable hormone levels and minimize the fluctuations that might occur with immediate-release formulations.

When considering the use of this formulation, it is important to be aware of potential drug interactions. Estrogens can interact with a variety of medications, potentially altering their effects. For example, they may reduce the metabolism of drugs that are substrates of cytochrome P450 enzymes, particularly CYP3A4. This can lead to increased levels of drugs such as cyclosporine, theophylline, and corticosteroids, necessitating close monitoring and possible dose adjustments.

Conversely, certain medications can affect the metabolism of estrogens, potentially diminishing their effectiveness. These include enzyme inducers such as carbamazepine, phenytoin, rifampicin, and St. John's Wort, which can increase the clearance of estrogens and may require a dosage adjustment of the HRT. Patients should also be cautious when using thyroid hormone replacement therapy, as estrogens can increase thyroid-binding globulin (TBG) levels, leading to a decrease in free thyroid hormone levels and a need for a higher dose of thyroid medication.

Additionally, estrogens can have an impact on the anticoagulant effects of warfarin and other oral anticoagulants, necessitating careful monitoring of coagulation parameters and potential dose adjustments. They may also interfere with the pharmacokinetics of certain benzodiazepines, tricyclic antidepressants, and some beta-blockers. It is also important to note that smoking can reduce the efficacy of estrogen therapy and increase the risk of serious cardiovascular side effects, especially in women over 35 years of age.

Patients with diabetes should be aware that estrogen-containing products can affect glucose tolerance. Regular monitoring of blood glucose levels and possible adjustments to antidiabetic medication may be required. Furthermore, estrogens can increase the plasma concentrations of binding proteins such as corticosteroid-binding globulin (CBG), sex hormone-binding globulin (SHBG), leading to increased circulating corticosteroids and sex steroids, respectively. This may affect the action of these hormones and necessitate dose adjustments.

It is crucial for patients to inform their healthcare provider of all medications, supplements, and herbal products they are currently taking before starting Estradiol 0.5 mg/Estriol 2 mg Slow Release (MEM4) Oral Capsules. This will help to identify any potential interactions and allow for proper management. If you have any questions or require further information regarding drug interactions with this formulation, please reach out to us at Bayview Pharmacy for assistance.

How Does it Work

A small arrow pointing down

The Estradiol 0.5 mg/Estriol 2 mg Slow Release (MEM4) Oral Capsules are a specialized hormone replacement therapy (HRT) designed to alleviate symptoms associated with menopause and other conditions caused by estrogen deficiency. This formulation combines two forms of estrogen: estradiol, the primary and most potent form of estrogen, and estriol, a weaker form of estrogen. By incorporating both, the capsules aim to provide a balanced approach to estrogen supplementation, potentially reducing the risk of side effects associated with estrogen therapy.

The key to the slow-release mechanism of these capsules lies in the use of Methocel E4M, a hydrophilic methylcellulose derivative. Methocel E4M is a high-viscosity grade of hypromellose, which forms a gel-like matrix when it comes into contact with gastric fluids. This matrix creates a barrier that controls the rate at which the active ingredients, estradiol and estriol, are released into the bloodstream. As the capsule travels through the gastrointestinal tract, the Methocel E4M gradually hydrates and swells, allowing a consistent and controlled release of the hormones over an extended period. This slow dissolution process ensures that the patient receives a steady dose of the medication, which can help maintain stable hormone levels and reduce the frequency of dosing.

The controlled-release feature of these capsules is particularly beneficial for patients who require long-term estrogen therapy. By providing a steady release of estrogen, the formulation helps to manage symptoms such as hot flashes, night sweats, vaginal dryness, and mood swings, which are commonly experienced during menopause. Additionally, the sustained release of hormones can help in the prevention of osteoporosis, a condition characterized by weakened bones that is often exacerbated by low estrogen levels. The slow-release capsules may also be used in other estrogen-deficient states as determined by a healthcare provider.

For prescribers, it is important to note that the use of any estrogen therapy should be individualized based on the patient's specific needs and risk factors. The Estradiol 0.5 mg/Estriol 2 mg Slow Release (MEM4) Oral Capsules offer a unique option for patients who may benefit from a controlled-release hormone therapy. It is essential to monitor patients regularly to assess the efficacy and safety of the treatment, and to make any necessary adjustments to the dosing regimen.

Patients should be advised that while the slow-release formulation is designed to improve compliance and minimize fluctuations in hormone levels, it is still crucial to adhere to the prescribed dosing schedule. They should also be informed about the potential side effects of estrogen therapy and the importance of reporting any unusual symptoms to their healthcare provider.

If you have any questions or require further information about the Estradiol 0.5 mg/Estriol 2 mg Slow Release (MEM4) Oral Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide support and guidance to both patients and prescribers to ensure the safe and effective use of this formulation.

Other Uses

A small arrow pointing down

Aside from its primary indication, the combination of estradiol and estriol in a slow-release capsule formulation may offer other benefits beyond the commonly prescribed uses for hormone replacement therapy in menopause. This unique combination takes advantage of the distinct properties of each estrogen. Estriol, being a weaker estrogen, may contribute to fewer side effects and is often touted for its potential protective effects on the urogenital tract, possibly reducing the risk of recurrent urinary tract infections and improving vaginal atrophy symptoms without significantly stimulating the endometrium. Estradiol, on the other hand, is a more potent estrogen commonly used to alleviate a broader spectrum of menopausal symptoms such as hot flashes, night sweats, and osteoporosis.

The slow release (SR) formulation offered by Memocel E4M can allow for a sustained, stable release of hormones, which may result in a more consistent estrogenic effect over time, potentially leading to steadier relief of symptoms and possibly resulting in a reduction of the fluctuation-related side effects sometimes associated with estrogen therapy. Furthermore, the SR formulation may offer a reduction in the frequency of dosage, which could enhance adherence to therapy, an important consideration in chronic conditions.

Another potential use of this formulation, though less common and requiring further research, is for the support of skin health. Estrogens have a role in maintaining skin elasticity and thickness; therefore, a controlled release of these hormones might help to slow the process of skin aging. Additionally, in certain dermatological conditions where estrogen therapy has been found beneficial, such as in acne or androgenetic alopecia in females, the MEM4 capsule may have a use, although it is not typically a first-line treatment for these conditions.

In some cases, women transitioning through menopause may experience an exacerbation of autoimmune conditions. There is some evidence that estrogens can modulate immune function, and potentially, this sustained-release hormonal therapy could have an adjunct role in the management of such conditions, though this would require careful monitoring and is not a standard indication.

Lastly, there is exploratory interest in the use of hormone replacement for the prevention of cognitive decline, as some research suggests estrogens may have neuroprotective effects. However, this is an area of ongoing debate and investigation, and the MEM4 slow-release capsules would only be recommended under a research protocol or if future evidence supports such use.

Patients and prescribers must note that while this extended-release delivery system has potential benefits, the use in conditions outside the well-established indications should be approached with caution. Decisions on therapy must always be based on a thorough evaluation of risks versus benefits in the context of a patient's complete medical history. For any questions or further information on potential other uses of Estradiol 0.5 mg/Estriol 2 mg Slow Release (MEM4) Oral Capsules, please reach out to us at Bayview Pharmacy. Our compounding pharmacists are here to provide the answers and guidance you need.

Frequently Asked Questions

A small arrow pointing down

What is Estradiol/Estriol MEM4 Oral Capsule?

The Estradiol/Estriol MEM4 Oral Capsule is a compounded formulation containing 0.5 mg of Estradiol and 2 mg of Estriol. This medication is designed to be released slowly over time to provide sustained hormone levels for women who may require hormone replacement therapy.

What is Methocel E4M and how does it work in this medication?

Methocel E4M is a controlled-release polymer used in the capsules to ensure the medication is released gradually. It slows down the release of the active ingredients, providing a prolonged therapeutic effect and reducing the need for frequent dosing.

What are the benefits of taking Estradiol/Estriol MEM4 Oral Capsules?

By using a slow-release formula, patients experience a more consistent hormone level, which can lead to reduced side effects and improved symptom control. It also means taking medication less frequently, which can help improve patient compliance with their treatment regimen.

How often should I take Estradiol/Estriol MEM4 Oral Capsules?

The dosing regimen for Estradiol/Estriol MEM4 Oral Capsules can vary based on individual needs. It's important to follow the prescription provided by your healthcare provider, who will determine the best dosing schedule for your condition.

Can I take Estradiol/Estriol MEM4 Oral Capsules with food?

Yes, you can take Estradiol/Estriol MEM4 Oral Capsules with or without food. However, consistency is key, so try to take it the same way each time to maintain even drug levels in your body.

What should I do if I miss a dose of Estradiol/Estriol MEM4 Oral Capsules?

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up.

Are there any side effects associated with Estradiol/Estriol MEM4 Oral Capsules?

As with any medication, there can be side effects. Common side effects may include nausea, headache, breast tenderness, or spotting. If you experience any severe side effects or symptoms that persist, contact your healthcare provider immediately.

Can I split or crush the Estradiol/Estriol MEM4 Oral Capsules?

No, these capsules should not be split or crushed as it would interfere with the controlled-release mechanism and could lead to the release of the medication too quickly.

Will Estradiol/Estriol MEM4 Oral Capsules affect my current medications?

It is important to discuss all your current medications with your healthcare provider, as hormone therapies can interact with other drugs. Provide a full list of medications, including supplements, to determine if the Estradiol/Estriol MEM4 capsules are safe for you.

How should I store Estradiol/Estriol MEM4 Oral Capsules?

Store Estradiol/Estriol MEM4 Oral Capsules at room temperature, away from moisture and heat. Keep them out of reach of children and pets, and do not store them in bathroom cabinets due to the potential for high humidity.

Is Estradiol/Estriol MEM4 Capsule suitable for everyone who needs hormone replacement therapy?

No, this medication may not be suitable for everyone. Your healthcare provider will evaluate your individual health profile, including your medical history, and decide if this hormone therapy is appropriate for you.

Related Formulas

Related Products
Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
NEW PRESCRIPTION ORDER FORM
1
Circle for steps.
Patient Information
2
Circle for steps.
Prescriber and Prescription Information
3
Circle for steps.
Fax order form to Bayview Pharmacy at 401-284-4506.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.